QIAGEN N.V. (QGEN) Stock Fundamental Analysis
NYSE:QGEN - New York Stock Exchange, Inc. - NL0015002CX3 - Common Stock - Currency: USD
Overall QGEN gets a fundamental rating of 6 out of 10. We evaluated QGEN against 54 industry peers in the Life Sciences Tools & Services industry. QGEN gets an excellent profitability rating and is at the same time showing great financial health properties. QGEN is not valued too expensively and it also shows a decent growth rate. With these ratings, QGEN could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
QGEN had positive earnings in the past year.
QGEN had a positive operating cash flow in the past year.
Each year in the past 5 years QGEN has been profitable.
Each year in the past 5 years QGEN had a positive operating cash flow.
1.2 Ratios
QGEN's Return On Assets of 1.47% is fine compared to the rest of the industry. QGEN outperforms 70.37% of its industry peers.
With a decent Return On Equity value of 2.34%, QGEN is doing good in the industry, outperforming 68.52% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.14%, QGEN is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QGEN is significantly below the industry average of 16.18%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.14% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QGEN has a Profit Margin of 4.23%. This is in the better half of the industry: QGEN outperforms 70.37% of its industry peers.
QGEN's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 25.02%, QGEN belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
QGEN's Operating Margin has improved in the last couple of years.
QGEN has a Gross Margin of 63.82%. This is amongst the best in the industry. QGEN outperforms 90.74% of its industry peers.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
QGEN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
QGEN has less shares outstanding than it did 1 year ago.
QGEN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for QGEN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.61 indicates that QGEN is not in any danger for bankruptcy at the moment.
QGEN's Altman-Z score of 4.61 is amongst the best of the industry. QGEN outperforms 83.33% of its industry peers.
QGEN has a debt to FCF ratio of 2.77. This is a good value and a sign of high solvency as QGEN would need 2.77 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.77, QGEN is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that QGEN is not too dependend on debt financing.
QGEN has a Debt to Equity ratio (0.38) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.61 |
ROIC/WACC1.02
WACC7%
2.3 Liquidity
A Current Ratio of 3.61 indicates that QGEN has no problem at all paying its short term obligations.
QGEN has a Current ratio (3.61) which is in line with its industry peers.
A Quick Ratio of 3.09 indicates that QGEN has no problem at all paying its short term obligations.
QGEN has a Quick ratio (3.09) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.95% over the past year.
The Earnings Per Share has been growing by 8.25% on average over the past years. This is quite good.
QGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.66%.
Measured over the past years, QGEN shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
3.2 Future
Based on estimates for the next years, QGEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.10% on average per year.
The Revenue is expected to grow by 7.82% on average over the next years.
EPS Next Y8.56%
EPS Next 2Y8.59%
EPS Next 3Y8.95%
EPS Next 5Y9.1%
Revenue Next Year4.31%
Revenue Next 2Y5%
Revenue Next 3Y5.65%
Revenue Next 5Y7.82%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.72, which indicates a rather expensive current valuation of QGEN.
77.78% of the companies in the same industry are more expensive than QGEN, based on the Price/Earnings ratio.
QGEN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.03.
Based on the Price/Forward Earnings ratio of 19.20, the valuation of QGEN can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QGEN indicates a somewhat cheap valuation: QGEN is cheaper than 79.63% of the companies listed in the same industry.
QGEN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.72 | ||
| Fwd PE | 19.2 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QGEN is valued cheaper than 81.48% of the companies in the same industry.
QGEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. QGEN is cheaper than 79.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.53 | ||
| EV/EBITDA | 15.23 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QGEN may justify a higher PE ratio.
PEG (NY)2.54
PEG (5Y)2.63
EPS Next 2Y8.59%
EPS Next 3Y8.95%
5. Dividend
5.1 Amount
With a yearly dividend of 0.51%, QGEN is not a good candidate for dividend investing.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.53. QGEN pays more dividend than 90.74% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.51% |
5.2 History
QGEN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.59%
EPS Next 3Y8.95%
49.95
-0.3 (-0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.78%
Inst Owner Change-0.12%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap10.82B
Analysts76.67
Price Target51.54 (3.18%)
Short Float %2.96%
Short Ratio4.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.51% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)2.31%
PT rev (3m)2.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)0.15%
EPS NY rev (3m)2.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.72 | ||
| Fwd PE | 19.2 | ||
| P/S | 5.47 | ||
| P/FCF | 21.53 | ||
| P/OCF | 16.06 | ||
| P/B | 3.03 | ||
| P/tB | 12.91 | ||
| EV/EBITDA | 15.23 |
EPS(TTM)2.3
EY4.6%
EPS(NY)2.6
Fwd EY5.21%
FCF(TTM)2.32
FCFY4.64%
OCF(TTM)3.11
OCFY6.23%
SpS9.13
BVpS16.47
TBVpS3.87
PEG (NY)2.54
PEG (5Y)2.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.62% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.2% | ||
| ROICexgc | 29.06% | ||
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% | ||
| FCFM | 25.39% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.92 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 20.47 | ||
| Cash Conversion | 96.47% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.61 |
F-Score7
WACC7%
ROIC/WACC1.02
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.56%
EPS Next 2Y8.59%
EPS Next 3Y8.95%
EPS Next 5Y9.1%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.31%
Revenue Next 2Y5%
Revenue Next 3Y5.65%
Revenue Next 5Y7.82%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year58.48%
EBIT Next 3Y22.89%
EBIT Next 5Y16.26%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%